Drug Topics - October 22, 2007 - (Page 4)

4 DRUG TOPICS OCTOBER 22, 2007 www.drugtopics.com 123 Tice Boulevard, Suite 300 Woodcliff Lake, N.J. 07677 Main numbers: (201) 690-5300 or (888) 581-8052 Main fax number: (201) 690-5400 Customer Service: 1-877-922-2022 Classified and Recruitment Sales: 800-225-4569 ext. 2701 E-mail address: drugtopics@advanstar.com Web site: http://www.drugtopics.com Business hours: 8:30 A.M.–5:00 P.M. EDITORIAL Editor-in-Chief Judy C. Chi (201) 690-5327 jchi@advanstar.com Managing Editor Daniel Breeman (201) 690-5323 dbreeman@advanstar.com Clinical Editor Heidi Belden, Pharm.D. (508) 846-4165 hbelden@advanstar.com Managing Editor - Projects Sandra Levy (201) 690-5396 slevy@advanstar.com Senior Editors Michael Barbella (201) 690-5335 mbarbella@advanstar.com Nancy Jillard (201) 690-5329 njillard@advanstar.com Marina Marketos (201) 690-5399 mmarketos@advanstar.com Reid Paul (201) 690-5392 rpaul@advanstar.com Contributing Editors Fred Gebhart Jim Plagakis, R.Ph. Editorial Coordinator Nedda Tichi (201) 690-5398 ntichi@advanstar.com Joseph Loggia Chief Executive Officer SALES & MARKETING Publisher Joe Laborsky, R.Ph. (201) 690-5397 jlaborsky@advanstar.com National Sales Director Steven E. Anthony (201) 690-5324 santhony@advanstar.com National Sales Manager Jason O'Grady (847) 441-3769 jogrady@advanstar.com Senior Account Manager Maureen Dominguez (201) 690-5328 sdominguez@advanstar.com Marketing Director Susan Haber (201) 690-5403 Sales Support Administrator Monica Pellegrino (201) 690-5423 List Manager Renée Schuster (888) 736-8547 ext. 3113 Classified Recruitment Scott Eigenbrod (800) 225-4569 ext. 3170 Classified Sales Karen Eckenwiler (800) 225-4569 ext. 2670 Reprint Services FosteReprints (800) 344-8915 advanstarreprints @fostereprints.com PRODUCTION Senior Art Director Anne Pompeo (201) 690-5554 Art Director Thomas Darnsteadt (201) 690-5549 Senior Graphic Designer Sandy Schultz (201) 690-5557 Senior Production Manager Jane Dzuck (218) 740-6313 CIRCULATION Director, Circulation Christine Shappell (201) 690-5316 RESEARCH Director, Corporate Research Harry Ann Pearce (212) 951-6670 Senior Survey Specialist Scott Spiegel (212) 951-6649 ADVANSTAR LIFE SCIENCES R. Steve Morris Executive Vice President Laura Wagner Vice President Operations David Hoo Vice President of Marketing Tom Roesle Director of Finance Rick Treese Vice President and Chief Technology Officer Ted Alpert EST Vice President, Finance, CFO and Secretary Ward D. Hewins Vice President, General Counsel R. Steve Morris Daniel M. Phillips Executive Vice Presidents Adele D. Hartwick Vice President, Treasurer and Controller Patricia Joseph Vice President and Chief Marketing Officer Eric I. Lisman Executive Vice President Corporate Development Francis Heid Vice President, Media Operations Nancy Nugent Vice President Human Resources Drug Topics (ISSN# 0012-6616) is published twice a month except December (once) and Drug Topics Digital Edition (ISSN# pending) is issued every week by Advanstar Communications, Inc., 131 West First St., Duluth, MN 55806-2065. One-year subscription rates: $61 in the United States & Possessions; $109 in Canada and Mexico; all other countries, $109. Single copies (prepaid only) $10 in the United States; $10 in Canada and Mexico; all other countries, $15. Include $6 per copy for U.S. postage and handling. Periodicals postage paid at Duluth, MN 55806 and additional mailing offices. POSTMASTER: Please send address changes to Drug Topics, P Box 6079, Duluth, MN 55806-6079. Canadian G.S.T. number: R-124213133RT001. Publications Mail Agreement Number 40017597 Printed in the U.S.A. .O. . Subscription inquiries/address changes: toll-free (888) 527-7008, or dial direct (218) 723-9477 Copyright ©2007 Advanstar Communications Inc. All rights reserved. No part of this publication may . be reproduced or transmitted in any form or by any means, electronic or mechanical including by photocopy, recording, or information storage and retrieval without permission in writing from the publisher. Authorization to photocopy items for internal/educational or personal use, or the internal/educational or personal use of specific clients is granted by Advanstar Communications Inc. for libraries and other users registered with the Copyright Clearance Center, 222 Rosewood Dr. Danvers, MA 01923, 978-750-8400 fax 978-646-8700. For uses beyond those listed above, please direct your written request to Permission Dept. fax 440-891-2650. Microfilm or microfiche copies of issues are available through Advanstar Marketing Services, (800) 225-4569, Ext. 839. Unsolicited manuscripts, photographs, art, and other material will not be returned. Publisher assumes no responsibility for unsolicited manuscripts, photographs, art, and other material. Advanstar Communications provides certain customer contact data (such as customers’ names, addresses, phone numbers, and e-mail addresses) to third parties who wish to promote relevant products, services, and other opportunities that may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call toll-free (888) 527-7008 between the hours of 7:30 am and 5 pm CT and a customer service representative will assist you in removing your name from Advanstar’s lists. Outside the U.S., please phone (218) 723-9477 . DRUG TOPICS does not verify any claims or other information appearing in any of the advertisements contained in the publication, and cannot take responsibility for any losses or other damages incurred by readers in reliance on such content. DRUG TOPICS welcomes unsolicited articles, manuscripts, photographs and other materials but cannot be held responsible for their safekeeping or return. http://www.drugtopics.com http://www.drugtopics.com

Table of Contents Feed for the Digital Edition of Drug Topics - October 22, 2007

Drug Topics - October 22, 2007 Contents Latebreakers Legislative Victory Builds Momentum for Pharmacy Month Letters Health-System Edition R.Ph.s Brace for Payment Denial for Hospital-Acquired Conditions Topical Human Thrombin Helps Arrest Bleeding FDA Panels Fail to Set Target Levels for Renal Patients’ Hemoglobin Warning Letters Raise Patient Safety Concerns for Fentora Ending/Reversing Weight Gain Man Given Fatal Drug Overdose at Staten Island Hospital Pharmacists Playing More Important Role in Dialysis Treatment AHA President R.Ph.'s Here's How You Can Increase Your Value Premier Launches Comprehensive Quality Improvement Project FDA Approves Dexrazoxane for Treatment of Extravasation New Federal, State Reforms to Ease Disaster Relief Kinks 150 Years of American Pharmacy Ten Tips for MTM Success Independent Superstars: The Ones to Watch The New Dynamic Duo A Parkinson's Disease Primer Classified New Products Advertisers Index Viewpoint

Drug Topics - October 22, 2007

For optimal viewing of this digital publication, please enable JavaScript and then refresh the page. If you would like to try to load the digital publication without using Flash Player detection, please click here.